Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BLAKE SINGLETARY

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1316341787
CMS profile
2785139
Location
SARASOTA, FL

General Payments · PY2018–2024

$8,540.45

  • Reported across 167 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$562.48

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $562.48 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $976.49 15
PY2019 $2,412.69 41
PY2020 $1,583.29 26
PY2021 $1,633.08 30
PY2022 $555.04 16
PY2023 $817.38 25
PY2024 $562.48 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $187.66 02/22/2024 Food and Beverage Undisputed 01/23/2026 1124984602 CMS
Abbott Laboratories $146.56 08/29/2024 Food and Beverage Undisputed 01/23/2026 1124984606 CMS
Amgen Inc. $15.84 12/04/2024 Food and Beverage Undisputed 01/23/2026 1111710184 CMS
AstraZeneca Pharmaceuticals LP $13.28 02/21/2024 Food and Beverage Undisputed 01/23/2026 1105273827 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.22 06/05/2024 Food and Beverage Undisputed 01/23/2026 1117960196 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.37 09/25/2024 Food and Beverage Undisputed 01/23/2026 1117960194 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $21.00 12/16/2024 Food and Beverage Undisputed 01/23/2026 1117960198 CMS
Novartis Pharmaceuticals Corporation $15.48 12/11/2024 Food and Beverage Undisputed 01/23/2026 1087344585 CMS
PFIZER INC. $15.87 11/19/2024 Food and Beverage Undisputed 01/23/2026 1131094521 CMS
Philips North America LLC $34.13 01/25/2024 Food and Beverage Undisputed 01/23/2026 1146858546 CMS
Philips North America LLC $16.46 11/26/2024 Food and Beverage Undisputed 01/23/2026 1146858548 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $21.87 03/06/2024 Food and Beverage Undisputed 01/23/2026 1080573085 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $24.48 04/25/2024 Food and Beverage Undisputed 01/23/2026 1080573087 CMS
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $20.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 1080573093 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.